Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study.

IF 3.1 2区 医学 Q2 ONCOLOGY
Journal of Cancer Survivorship Pub Date : 2025-02-01 Epub Date: 2023-09-22 DOI:10.1007/s11764-023-01456-4
Sven Strebel, Katja Baust, Desiree Grabow, Julianne Byrne, Thorsten Langer, Antoinette Am Zehnhoff-Dinnesen, Rahel Kuonen, Annette Weiss, Tomas Kepak, Jarmila Kruseova, Claire Berger, Gabriele Calaminus, Grit Sommer, Claudia E Kuehni
{"title":"Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study.","authors":"Sven Strebel, Katja Baust, Desiree Grabow, Julianne Byrne, Thorsten Langer, Antoinette Am Zehnhoff-Dinnesen, Rahel Kuonen, Annette Weiss, Tomas Kepak, Jarmila Kruseova, Claire Berger, Gabriele Calaminus, Grit Sommer, Claudia E Kuehni","doi":"10.1007/s11764-023-01456-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Auditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications-particularly tinnitus-on health-related quality of life (HRQoL) among childhood cancer survivors (CCS). We determined the prevalence of hearing loss and tinnitus in the European PanCareLIFE cohort of CCS and examined its effect on HRQoL.</p><p><strong>Methods: </strong>We included CCS from four European countries who were diagnosed at age ≤ 18 years; survived ≥ 5 years; and aged 25-44 years at study. We assessed HRQoL (Short Form 36), hearing loss, and tinnitus using questionnaires. We used multivariable linear regression to examine associations between these two auditory complications and HRQoL adjusting for socio-demographic and clinical factors.</p><p><strong>Results: </strong>Our study population consisted of 6,318 CCS (53% female; median age at cancer diagnosis 9 years interquartile range [IQR] 5-13 years) with median age at survey of 31 years (IQR 28-35 years). Prevalence was 7.5% (476/6,318; confidence interval [CI]: 6.9-8.2) for hearing loss and 7.6% (127/1,668; CI: 6.4-9.0) for tinnitus. CCS with hearing loss had impaired physical (coefficient [coef.] -4.3, CI: -7.0 to -1.6) and mental (coef. -3.2, CI: -5.5 to -0.8) HRQoL when compared with CCS with normal hearing. Tinnitus was associated with impaired physical (coef. -8.2, CI: -11.8 to -4.7) and mental (coef. -5.9, CI: -8.8 to -3.1) HRQoL.</p><p><strong>Conclusion: </strong>We observed reduced HRQoL among CCS with hearing loss and tinnitus. Our findings indicate timely treatment of hearing loss and tinnitus may contribute to quality of life of survivors.</p><p><strong>Implications for cancer survivors: </strong>CCS who experience auditory complications should be counseled about possible therapeutic and supportive measures during follow-up care.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":"162-173"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813997/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Survivorship","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11764-023-01456-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/22 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Auditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications-particularly tinnitus-on health-related quality of life (HRQoL) among childhood cancer survivors (CCS). We determined the prevalence of hearing loss and tinnitus in the European PanCareLIFE cohort of CCS and examined its effect on HRQoL.

Methods: We included CCS from four European countries who were diagnosed at age ≤ 18 years; survived ≥ 5 years; and aged 25-44 years at study. We assessed HRQoL (Short Form 36), hearing loss, and tinnitus using questionnaires. We used multivariable linear regression to examine associations between these two auditory complications and HRQoL adjusting for socio-demographic and clinical factors.

Results: Our study population consisted of 6,318 CCS (53% female; median age at cancer diagnosis 9 years interquartile range [IQR] 5-13 years) with median age at survey of 31 years (IQR 28-35 years). Prevalence was 7.5% (476/6,318; confidence interval [CI]: 6.9-8.2) for hearing loss and 7.6% (127/1,668; CI: 6.4-9.0) for tinnitus. CCS with hearing loss had impaired physical (coefficient [coef.] -4.3, CI: -7.0 to -1.6) and mental (coef. -3.2, CI: -5.5 to -0.8) HRQoL when compared with CCS with normal hearing. Tinnitus was associated with impaired physical (coef. -8.2, CI: -11.8 to -4.7) and mental (coef. -5.9, CI: -8.8 to -3.1) HRQoL.

Conclusion: We observed reduced HRQoL among CCS with hearing loss and tinnitus. Our findings indicate timely treatment of hearing loss and tinnitus may contribute to quality of life of survivors.

Implications for cancer survivors: CCS who experience auditory complications should be counseled about possible therapeutic and supportive measures during follow-up care.

Abstract Image

儿童癌症幸存者的听觉并发症与健康相关的生活质量:PanCareLIFE研究。
目的:听觉并发症是儿童癌症治疗的潜在副作用。然而,关于听觉并发症(尤其是锡)对癌症儿童幸存者健康相关生活质量(HRQoL)的影响的证据有限。我们确定了CCS的欧洲PanCareLIFE队列中听力损失和耳鸣的患病率,并检查了其对HRQoL的影响。方法:我们纳入了来自四个欧洲国家的CCS,这些国家在年龄 ≤ 18岁;幸存下来 ≥ 5年;年龄25-44岁。我们使用问卷调查评估了HRQoL(简表36)、听力损失和耳鸣。我们使用多变量线性回归来检验这两种听觉并发症与HRQoL之间的关系,并根据社会人口统计学和临床因素进行调整。结果:我们的研究人群包括6318名CCS(53%为女性;癌症诊断时的中位年龄为9年四分位间距[IQR]5-13岁),调查时的中位数年龄为31岁(IQR 28-35岁)。听力损失患病率为7.5%(476/6318;置信区间[CI]:6.9-8.2),耳鸣患病率为7.6%(127/1668;置信区间:6.4-9.0)。与听力正常的CCS相比,听力损失的CCS的身体(系数[系数]-4.3,CI:-7.0-1.6)和精神(系数-3.2,CI:-5.5--0.8)HRQoL受损。耳鸣与身体(系数-8.2,CI:-11.8至-4.7)和精神(系数-5.9,CI:-8.8至-3.1)HRQoL受损有关。结论:在伴有听力损失和耳鸣的CCS患者中,我们观察到HRQoL降低。我们的研究结果表明,及时治疗听力损失和耳鸣可能有助于提高幸存者的生活质量。对癌症幸存者的影响:经历听觉并发症的CCS应在后续护理期间咨询可能的治疗和支持措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.00
自引率
10.80%
发文量
149
审稿时长
>12 weeks
期刊介绍: Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信